Gaoquan Li

503 total citations
24 papers, 377 citations indexed

About

Gaoquan Li is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Gaoquan Li has authored 24 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Gaoquan Li's work include DNA Repair Mechanisms (8 papers), Cancer-related Molecular Pathways (8 papers) and Cancer therapeutics and mechanisms (4 papers). Gaoquan Li is often cited by papers focused on DNA Repair Mechanisms (8 papers), Cancer-related Molecular Pathways (8 papers) and Cancer therapeutics and mechanisms (4 papers). Gaoquan Li collaborates with scholars based in United States, China and United Kingdom. Gaoquan Li's co-authors include Thomas J. Sowin, Nan‐Horng Lin, Stephen F. Nelsen, Saul H. Rosenberg, Zehan Chen, Peter Kovar, Zhi‐Fu Tao, Hing L. Sham, Zhan Xiao and Yunsong Tong and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Gaoquan Li

24 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaoquan Li United States 11 205 134 98 56 42 24 377
Katja Kräling Germany 9 244 1.2× 270 2.0× 309 3.2× 75 1.3× 26 0.6× 12 580
Song Lian China 14 277 1.4× 110 0.8× 188 1.9× 44 0.8× 33 0.8× 17 642
Zixiang Huang China 11 243 1.2× 82 0.6× 99 1.0× 66 1.2× 10 0.2× 20 409
Shendong Yuan United States 11 253 1.2× 88 0.7× 176 1.8× 44 0.8× 12 0.3× 20 524
Douglas W. Thomson United Kingdom 15 241 1.2× 65 0.5× 549 5.6× 49 0.9× 35 0.8× 19 799
Kevin J. Lee United States 12 201 1.0× 116 0.9× 233 2.4× 29 0.5× 18 0.4× 27 579
Ka‐Chung Tong Hong Kong 8 123 0.6× 130 1.0× 125 1.3× 96 1.7× 23 0.5× 10 361
Soo Yei Ho Singapore 12 364 1.8× 349 2.6× 274 2.8× 44 0.8× 11 0.3× 30 751
Shenlin Huang United States 14 228 1.1× 123 0.9× 513 5.2× 66 1.2× 76 1.8× 26 765
Lingli Sun China 8 176 0.9× 133 1.0× 119 1.2× 271 4.8× 38 0.9× 14 616

Countries citing papers authored by Gaoquan Li

Since Specialization
Citations

This map shows the geographic impact of Gaoquan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaoquan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaoquan Li more than expected).

Fields of papers citing papers by Gaoquan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaoquan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaoquan Li. The network helps show where Gaoquan Li may publish in the future.

Co-authorship network of co-authors of Gaoquan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Gaoquan Li. A scholar is included among the top collaborators of Gaoquan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaoquan Li. Gaoquan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Zhao, Hong Fang, Yale Jiang, et al.. (2024). Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood–brain barrier. Acta Pharmaceutica Sinica B. 14(6). 2786–2789. 3 indexed citations
3.
Li, Gaoquan, et al.. (2016). Transcriptional profiling of rat skeletal muscle hypertrophy under restriction of blood flow. Gene. 594(2). 229–237. 7 indexed citations
4.
Li, Gaoquan, et al.. (2013). [Research advance on signaling pathways and protein metabolism for skeletal muscle disuse atrophy].. PubMed. 26(11). 969–72. 1 indexed citations
5.
Li, Gaoquan, Stephen F. Nelsen, Almaz S. Jalilov, & Ilia A. Guzei. (2010). O-Capped Heteroadamantyl-Substituted Hydrazines and Their Oxidation Products. The Journal of Organic Chemistry. 75(8). 2445–2452. 11 indexed citations
6.
Rosspeintner, Arnulf, Markus Grießer, Yoshio Teki, et al.. (2010). EPR and ENDOR Studies of Dimeric Paracyclophane Radical Cations and Dications Containing Tri- and Pentamethylene-Bridged p-Phenylene Diamine Units. The Journal of Physical Chemistry A. 114(23). 6487–6492. 12 indexed citations
7.
Xiao, Zhan, John Xue, Wen‐Zhen Gu, et al.. (2008). Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors. Biomarkers. 13(6). 579–596. 20 indexed citations
8.
Nelsen, Stephen F., et al.. (2008). Alkylated Trimethylene-Bridged Bis(p-Phenylenediamines). Journal of the American Chemical Society. 130(35). 11620–11622. 29 indexed citations
9.
Tong, Yunsong, Zhi‐Fu Tao, Jennifer J. Bouska, et al.. (2007). Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Improving oral biovailability. Bioorganic & Medicinal Chemistry Letters. 17(20). 5665–5670. 5 indexed citations
10.
Li, Gaoquan, Zhi‐Fu Tao, Yunsong Tong, et al.. (2007). Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(23). 6499–6504. 9 indexed citations
11.
Tao, Zhi‐Fu, Gaoquan Li, Yunsong Tong, et al.. (2007). Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4308–4315. 22 indexed citations
12.
Tao, Zhi‐Fu, Gaoquan Li, Yunsong Tong, et al.. (2007). Discovery of 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2′-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5944–5951. 25 indexed citations
13.
Li, Gaoquan, Lisa Hasvold, Zhi‐Fu Tao, et al.. (2006). Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(8). 2293–2298. 29 indexed citations
14.
Chen, Zehan, Zhan Xiao, Wen‐Zhen Gu, et al.. (2006). Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics. International Journal of Cancer. 119(12). 2784–2794. 103 indexed citations
15.
Wang, Gary T., Gaoquan Li, Robert A. Mantei, et al.. (2005). 1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase:  Synthesis, Preliminary SAR, and Biological Activities. Journal of Medicinal Chemistry. 48(9). 3118–3121. 35 indexed citations
16.
Link, J. T., Bryan K. Sorensen, David L. Arendsen, et al.. (2004). Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulators. Bioorganic & Medicinal Chemistry Letters. 14(16). 4169–4172. 8 indexed citations
17.
Li, Gaoquan, et al.. (1997). Studies on the laser degradation of the CHCl3 solution of polysilane. Journal of Applied Polymer Science. 66(8). 1515–1519. 1 indexed citations
18.
Li, Gaoquan, et al.. (1996). Studies on the fluorescence quenching of anthracenes by polysilane copolymers. Journal of Applied Polymer Science. 59(9). 1463–1466. 4 indexed citations
19.
Li, Gaoquan, et al.. (1996). Studies on the fluorescence quenching of polysilane copolymers by chlorohydrocarbons. Journal of Polymer Science Part B Polymer Physics. 34(9). 1583–1589. 4 indexed citations
20.
Bai, Fenglian, et al.. (1996). Fluorescence Quenching Study on Some Substituted Polysilanes. Polymers for Advanced Technologies. 7(2). 92–94. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katja Kräling Breakdown of academic impact, for papers by Song Lian Breakdown of academic impact, for papers by Zixiang Huang Breakdown of academic impact, for papers by Shendong Yuan Breakdown of academic impact, for papers by Douglas W. Thomson Breakdown of academic impact, for papers by Kevin J. Lee Breakdown of academic impact, for papers by Ka‐Chung Tong Breakdown of academic impact, for papers by Soo Yei Ho Breakdown of academic impact, for papers by Shenlin Huang Breakdown of academic impact, for papers by Lingli Sun
Rankless by CCL
2026